ASHOK KUMAR to Treatment Outcome
This is a "connection" page, showing publications ASHOK KUMAR has written about Treatment Outcome.
Connection Strength
0.019
-
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report. BMC Cancer. 2015 May 13; 15:400.
Score: 0.009
-
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs. 2008 Feb; 26(1):81-7.
Score: 0.006
-
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2003 Jul; 122(1):128-34.
Score: 0.004